McGill Pain Questionnaire

Also found in: Encyclopedia, Wikipedia.

McGill Pain Questionnaire

A two-part instrument developed at McGill University by Melzack and Torgerson in 1971, which is used to evaluate subjective components of pain.

McGill Pain Questionnaire Parts
• Part 1—One simple question: the patient categorises the pain on a scale of 0 (no pain) to 5 (excruciating pain).
• Part 2—Contains 77 pain descriptors, e.g., cramping, burning, which are grouped into 20 categories; the descriptors in each category are ranked numerically according to pain severity.

McGill Pain Questionnaire

Neurology A 2-part instrument used to evaluate subjective components of pain

McGill Pain Questionnaire

[McGill University, Montreal, Canada, where the questionnaire was developed]


An instrument used to quantify the perceived location, type, and magnitude of pain. A typical McGill Pain Questionnaire consists of three parts: location of the source of pain as depicted by marking one or more X's on a diagram; the intensity of pain as indicated by a visual analog scale; and the magnitude of pain by selecting words from a pain rating index.

McGill University,

university in Montreal, Canada, where questionnaire was developed.
McGill Pain Questionnaire - used to quantify location, type, and magnitude of pain.
Mentioned in ?
References in periodicals archive ?
The pain related either with needling or with needle withdrawal was quantified using a validated visual analogue scale (VAS) and the Short-Form McGill Pain Questionnaire (SF-MPQ).
The Short-Form McGill Pain Questionnaire (SFMPQ) pain rating scale consists of 15 pain descriptors (11 sensory, 4 affective) that are rated for intensity on a Likert scale from 0 (none) to 3 (severe) [23].
After obtaining consent, a package of forms and questionnaires were mailed to the participants that included: a sheet of instructions for completion, a form to record medications and comorbid health conditions, the McGill Pain Questionnaire (MPQ) and the Brief Pain Inventory (BPI).
Specifically these were a visual analogue scale of pain intensity (Langley & Sheppeard, 1985) and the McGill Pain Questionnaire (Melzack, 1975) which was developed for an adult population.
They used two tools recommended by the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT), which is endorsed by the Food and Drug Administration: the Brief Pain Inventory (BPI), which captures the effect of pain on physical functioning, and the Short-Form McGill Pain Questionnaire 2 (SF-MPQ-2), which evaluates the nature of pain using 22 descriptors that are grouped into four overarching types of pain.
We used two instruments to measure the symptom variable of pain: The Brief Pain Inventory Long Form (BPI-LF) and the McGill Pain Questionnaire.
As compared with placebo, both doses of ulipristal acetate led to reductions in pain (especially moderate or severe pain), as measured with the Short-Form McGill Pain Questionnaire.
In 1975, Melzack combined these to produce the McGill Pain Questionnaire which became an important tool in the study of clinical pain (11).
Adult Measures of Pain The McGill Pain Questionnaire (MPQ), Rheumatoid Arthritis Pain Scale (RAPS), Short-Form McGill Pain Questionnaire (SF-MPQ), Verbal Descriptive Scale (VDS), Visual Analog Scale (VAS), and West Haven-Yale Multidisciplinary Pain Inventory (WHYMPI).
Results: The authors found that the group receiving hypnosis had a significant drop in pain compared with the control group when measured by the McGill Pain Questionnaire but not when measured by other pain rating scales.
The primary endpoint was patient-reported breast pain immediately after radioisotope injection, using the Wong-Baker FACES pain rating scale and McGill pain questionnaire, analyzed in the per-protocol population.

Full browser ?